Home
>
National Drug Code (NDC)
>
Tranexamic Acid
Tranexamic Acid - 67457-293-10 - (tranexamic acid)
Drug Information of Tranexamic Acid
| Product NDC: | 67457-293 |
| Proprietary Name: | Tranexamic Acid |
| Non Proprietary Name: | tranexamic acid |
| Active Ingredient(s): | 100 mg/mL & nbsp; tranexamic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tranexamic Acid
| Product NDC: | 67457-293 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091657 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111129 |
Package Information of Tranexamic Acid
| Package NDC: | 67457-293-10 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (67457-293-10) > 10 mL in 1 VIAL, SINGLE-DOSE (67457-293-00) |
NDC Information of Tranexamic Acid
| NDC Code | 67457-293-10 |
| Proprietary Name | Tranexamic Acid |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (67457-293-10) > 10 mL in 1 VIAL, SINGLE-DOSE (67457-293-00) |
| Product NDC | 67457-293 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tranexamic acid |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20111129 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | TRANEXAMIC ACID |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
